Treatment with Exogenously Added Catalase Alters CD8 T Cell Memory Differentiation and Function

Abstract

Cell‐based immunotherapy is a promising approach to cancer treatment. However, the metabolically hostile tumor microenvironment (TME) poses a major barrier to this therapeutic approach. Metabolic reprogramming may enhance T cell effector function and support longevity and persistence within the TME. Metabolic processes lead reactive oxygen species (ROS) production, which are mandatory mediators of signaling and immune cell functions, but detrimental when present in excess. Catalase (CAT) is an intracellular antioxidant enzyme that scavenges hydrogen peroxide (H2O2), a central ROS member with a plethora of biological effects. H2O2 is produced intracellularly and extracellularly, diffusing freely between the two compartments. In this study, it is found that scavenging extracellular H2O2 by CAT supplementation has a major impact on the cell redox state, decreased intracellular ROS, but enhanced activation and altered memory differentiation. Under in vitro chronic activation conditions, CAT treatment favors CD8 T cells with less exhausted phenotype, increased activation and memory markers, and high bioenergetic capacity. Under in vitro acute activation conditions, CAT treatment selectively prevents differentiation transition from the stem cell memory/naive (TSCM/TN)‐ to the central memory (TCM)‐like phenotype, while enhancing activation and polyfunctionality. The study highlights the critical role of H2O2 as a “hidden player” in T cell fitness and memory differentiation.

Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer

“…The tumor microenvironment (TME) is a multifaceted cytosolic environment that both limits tumor development (25)(26)(27) and plays a key role in tumor progression and therapeutic response (28)(29)(30)(31). In lung adenocarcinoma (LUAD), they evaluated the correlation between the m6A-related lncRNA model and immunotherapy biomarkers, and the m6A-based classifier index can be used as a predictor of TIDE and TMB (32).…”

The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?

“…Elevated ROS levels and alterations in antioxidant capacity can disrupt immune cell functions, influencing their sensitivity to chemotherapeutic agents and immunotherapy. Excessive ROS in the extracellular environment can lead to T cell death [149] or dysfunction [150] and select immunosuppressive cells that possess stronger antioxidant defenses [151][152][153].…”

Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management

“…In inflammatory conditions, catalase activity reduces the excess formation of ROS, thereby mitigating tissue damage and inflammation associated with chronic inflammatory diseases and autoimmune disorders ( Figure 5 ). Moreover, catalase has been shown to modulate immune cell function, such as macrophage polarization and T cell activation, by regulating intracellular ROS levels [ 173 ]. The regulation of ROS by catalase can impact cytokine and chemokine production, thereby shaping the overall immune response to pathogens and antigens.…”